The ATA and the Brazilian Consensus recommend that patients with a personal or family history of Medullary Thyroid Cancer (MTC) should be evaluated for germline mutations of the RET proto-oncogene, regardless of age and the presence of thyroid nodules.
![](https://www.onkos.com.br/wp-content/uploads/2023/03/ata-logo-jpg-1.png)
![](https://www.onkos.com.br/wp-content/uploads/2023/03/ata-logo-jpg-1.png)